NCT03853590

Brief Summary

Non-randomized open label study to investigate factors mediating changes in insulin sensitivity, glucose tolerance and other metabolic outcomes after bariatric surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Feb 2010

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2010

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

February 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 25, 2019

Completed
Last Updated

February 25, 2019

Status Verified

February 1, 2019

Enrollment Period

3.1 years

First QC Date

February 22, 2019

Last Update Submit

February 22, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • fasting insulin

    circulating levels of fasting insulin measured in pmol/L

    Change from Baseline insulin at 6 months post-surgery

  • fasting glucose

    circulating levels of fasting glucose measured in mg/dl

    Change from Baseline insulin at 6 months post-surgery

  • Boost Challenge Test

    serum insulin and glucose levels after a mixed meal challenge (Boost Protein shake)

    Change from Baseline insulin at 6 months post-surgery

Study Arms (2)

Laparoscopic Adjustable Gastric Band

ACTIVE COMPARATOR

Subjects who elected to undergo Laparoscopic Adjustable Gastric Band intervention were examined prior to surgery and at 2, 3, 6 months after operation.

Procedure: Laparoscopic adjustable gastric banding

Roux-en-Y gastric bypass surgery

EXPERIMENTAL

Subjects who elected to undergo Roux-en-Y gastric bypass surgery were examined prior to surgery and at 2, 3, 6 months after operation.

Procedure: Roux-en-Y gastric bypass

Interventions

Creation of a small pouch from the stomach and connection of the newly created pouch directly to the small intestine so that swallowed food bypasses most of the stomach and the first section of the small intestine.

Roux-en-Y gastric bypass surgery

Placement of a soft silicone ring with an expandable balloon in the center, around the top part of the stomach to create a two-compartment stomach, with a much smaller top part above the band. The subject will eat enough food only to fill the top part of the stomach decreasing caloric consumption.

Laparoscopic Adjustable Gastric Band

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • males and females
  • years old
  • approved for bariatric surgery as per BIDMC Bariatric Clinic guidelines
  • English-speaking
  • willing and able to take part in a multi year study involving telephone interviews and enrolled prior to bariatric surgery

You may not qualify if:

  • Any condition that would exclude a patient from bariatric surgery as listed below:
  • patients with untreated major depression or psychosis
  • binge eating disorders
  • current drug and alcohol abuse
  • severe cardiac disease with prohibitive anesthetic risks
  • severe coagulopathy
  • inability to comply with nutritional requirements including life-long vitamin replacement.
  • pregnancy
  • Any additional condition not in accordance with standard of care as per Bariatric Clinic at BIDMC.
  • Any condition which in the opinion of the investigators rendered the candidate unsuitable for participation in this study.
  • history of any illness, other than obesity, that may affect insulin sensitivity (diabetes anemia, infectious diseases, renal or hepatic failure, uncontrolled hypertension, cancer or lymphoma)
  • subjects who required special diet prior to surgery
  • chronic inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis
  • states of cortisol or growth hormone excess
  • any medications that are known to influence glucose metabolism such as glucocorticoids
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Obesity

Interventions

Gastric Bypass

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Bariatric SurgeryBariatricsObesity ManagementTherapeuticsGastroenterostomyAnastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical Procedures

Study Officials

  • Christos Mantzoros, MD, PhD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Eligible patients were consecutively recruited and treatment allocation was decided after clinical evaluation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 22, 2019

First Posted

February 25, 2019

Study Start

February 25, 2010

Primary Completion

April 1, 2013

Study Completion

May 1, 2015

Last Updated

February 25, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations